Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Pharma-Bio Serv (PBSV) over the last 16 years, with Q4 2025 value amounting to $1.7 million.

  • Pharma-Bio Serv's Total Liabilities fell 3252.37% to $1.7 million in Q4 2025 from the same period last year, while for Oct 2025 it was $1.7 million, marking a year-over-year decrease of 3252.37%. This contributed to the annual value of $1.7 million for FY2025, which is 3252.37% down from last year.
  • Per Pharma-Bio Serv's latest filing, its Total Liabilities stood at $1.7 million for Q4 2025, which was down 3252.37% from $1.7 million recorded in Q3 2025.
  • Pharma-Bio Serv's 5-year Total Liabilities high stood at $8.9 million for Q1 2021, and its period low was $1.7 million during Q3 2025.
  • Its 5-year average for Total Liabilities is $4.0 million, with a median of $4.1 million in 2022.
  • Its Total Liabilities has fluctuated over the past 5 years, first soared by 7714.38% in 2021, then tumbled by 4786.33% in 2022.
  • Pharma-Bio Serv's Total Liabilities (Quarter) stood at $5.0 million in 2021, then decreased by 18.25% to $4.1 million in 2022, then dropped by 7.77% to $3.8 million in 2023, then plummeted by 31.74% to $2.6 million in 2024, then plummeted by 32.52% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q4 2025, $1.7 million for Q3 2025, and $1.8 million during Q2 2025.